Patent details

EP1142590 Title: GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE

Basic Information

Publication number:
EP1142590
PCT Application Number:
PCT/JP/2000/007502
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009716978
PCT Publication Number:
WO/2001/032220
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE
French Title of Invention:
THERAPIE GENIQUE POUR TRAITER LES MALADIES ISCHEMIQUES DIABETIQUES
German Title of Invention:
GENTHERAPIE FÜR DIABETISCHE ISCHÄMIE
SPC Number:

Dates

Filing date:
26/10/2000
Grant date:
01/10/2008
EP Publication Date:
01/10/2008
PCT Publication Date:
10/05/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/10/2001
EP B1 Publication Date:
01/10/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/10/2018
Expiration date:
26/10/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/10/2008
 
 

Name:
AnGes MG Inc.
Address:
7-7-15, Saito-Asagi,, Ibaraki-shi, Osaka, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/10/2008
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MORISHITA Ryuichi
Address:
Japan (JP)

2

Name:
OGIHARA Toshio
Address:
Japan (JP)

Priority

Priority Number:
30998499
Priority Date:
29/10/1999
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 48/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
09/10/2017
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1